Corona Mejora Tu Vida CORONA via flickr
The agreement includes an initial payment of $0.8 billion with a potential extra payment of $0.9 billion contingent on Regulus obtaining regulatory approval for the drug farabursen.
The agreement is anticipated to finalize in the latter half of the year following regulatory consent and meeting other requirements.
Novartis stock decreased by 0.7% at the close of trading on Wednesday. The value of Regulus securities jumped by 132% throughout the session on the Nasdaq exchange, with the company's market valuation approximately $223 million.
source: reuters.com
The agreement is anticipated to finalize in the latter half of the year following regulatory consent and meeting other requirements.
Novartis stock decreased by 0.7% at the close of trading on Wednesday. The value of Regulus securities jumped by 132% throughout the session on the Nasdaq exchange, with the company's market valuation approximately $223 million.
source: reuters.com
